Eiry Roberts, Chief Medical Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 2,228 shares at $132.96 ($296K) on 2024-02-13, disclosed to the SEC on 2024-02-15.
Scheduled sale ($296k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $132.96 | 1,114 | $148K | 50.0% |
| 2 | $132.96 | 1,114 | $148K | 50.0% |
| Total | $132.96 avg | 2,228 | $296K | 100% |
| Filing → |
| NBIX | SELL | 2025-02-04 | $445K | — | Filing → |
| NBIX | SELL | 2024-02-08 | $582K | — | Filing → |
| NBIX | SELL | 2024-02-02 | $410K | — | Filing → |